跳转至内容
Merck
CN
  • Effects of N-acetylcysteine and imipramine in a model of acute rhythm disruption in BALB/c mice.

Effects of N-acetylcysteine and imipramine in a model of acute rhythm disruption in BALB/c mice.

Chronobiology international (2014-10-07)
Luísa K Pilz, Yasmine Trojan, Caroline L Quiles, Radharani Benvenutti, Gabriela Melo, Rosa Levandovski, Maria Paz L Hidalgo, Elaine Elisabetsky
摘要

Circadian rhythm disturbances are among the risk factors for depression, but specific animal models are lacking. This study aimed to characterize the effects of acute rhythm disruption in mice and investigate the effects of imipramine and N-acetylcysteine (NAC) on rhythm disruption-induced changes. Mice were exposed to 12:12-hour followed by 10:10-hour light:dark cycles (LD); under the latter, mice were treated with saline, imipramine or NAC. Rhythms of rest/activity and temperature were assessed with actigraphs and iButtons, respectively. Hole-board and social preference tests were performed at the beginning of the experiment and again at the 8th 10:10 LD, when plasma corticosterone and IL-6 levels were also assessed. Actograms showed that the 10:10 LD schedule prevents the entrainment of temperature and activity rhythms for at least 13 cycles. Subsequent light regimen change activity and temperature amplitudes showed similar patterns of decline followed by recovery attempts. During the 10:10 LD schedule, activity and temperature amplitudes were significantly decreased (paired t test), an effect exacerbated by imipramine (ANOVA/SNK). The 10:10 LD schedule increased anxiety (paired t test), an effect prevented by NAC (30 mg/kg). This study identified mild but significant behavioral changes at specific time points after light regimen change. We suggest that if repeated overtime, these subtle changes may contribute to lasting behavioral disturbancess relevant to anxiety and mood disorders. Data suggest that imipramine may contribute to sustained rhythm disturbances, while NAC appears to prevent rhythm disruption-induced anxiety. Associations between sleep/circadian disturbances and the recurrence of depressive episodes underscore the relevance of potential drug-induced maintenance of disturbed rhythms.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.7%
Sigma-Aldrich
乙酸乙酯, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioReagent, suitable for cell culture
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, Sigma Grade, ≥99% (TLC), powder
Sigma-Aldrich
乙酸乙酯, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.8%
Sigma-Aldrich
乙酸乙酯, anhydrous, 99.8%
Sigma-Aldrich
肾上腺酮, ≥98.5% (HPLC)
Supelco
乙酸乙酯, analytical standard
Sigma-Aldrich
肾上腺酮, ≥92%
USP
乙酰半胱氨酸, United States Pharmacopeia (USP) Reference Standard
Supelco
N-乙酰基-L-半胱氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
乙酸乙酯, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioXtra, ≥99% (TLC)
Sigma-Aldrich
乙酸乙酯, ≥99%, FCC, FG
Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
乙酸乙酯, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, natural, ≥99%, FCC, FG
Sigma-Aldrich
乙酸乙酯, biotech. grade, ≥99.8%
Sigma-Aldrich
乙酸乙酯, ReagentPlus®, ≥99.8%
乙酰半胱氨酸, European Pharmacopoeia (EP) Reference Standard
Supelco
肾上腺酮, VETRANAL®, analytical standard
Sigma-Aldrich
Amyloid Protein Non-Aβ Component, ≥80% (HPLC)
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, Vetec, reagent grade, 98%